Dayforce
BonFry
hyrise
Pantera Capital
Brouxel & Rabia
SIXT
Talention
Republic Services
vertical cloud solution GmbH
Navitus Health Solutions
Aschert & Bohrmann GmbH
Aalberts surface technologies
A leading software solutions provider is seeking a Strategic Account Executive to drive customer acquisition and growth in the Biopharmaceutical sector from a remote position in Germany. The role involves engaging C-Suite decision makers, leading cross-functional teams, and delivering on sales targets. The ideal candidate has over 8 years of sales experience and a proven track record in SaaS deal closures. A great opportunity to impact the next generation of life sciences solutions.
IDBS is a dynamic and innovative company providing purpose-built software solutions to address the data management challenges prominent across the BioPharma lifecycle and supply chain.
Leveraging more than 30 years of experience in life science informatics, we are uniquely positioned to deliver a portfolio of innovative BioPharma knowledge management technologies to streamline the capture, analysis, reporting and sharing of data required to accelerate the next generation of life-changing therapies.
Cloud-native and analytics-centric, our platforms enable customers in research, development and manufacturing to efficiently and compliantly access critical data and insights to make faster, smarter decisions with greater confidence.
IDBS serves thousands of users across hundreds of organizations around the globe. Our predominant customer base is Life Sciences and includes 23 of the top 25 pharmaceutical companies and more than 250 small and medium-sized pharma and BioPharma companies, CROs, CDMOs and CMOs.
IDBS is one of 10 Life Sciences companies of Danaher. Together, we accelerate the discovery, development and delivery of solutions that safeguard and improve human health.
Do you want to work with a global, fast-paced, diverse team? Do you want to drive customer acquisition through SaaS software bookings and ARR growth across a targeted portfolio of Biopharmaceutical, pharmaceutical and CRO / CDMO accounts?
We are currently seeking a Strategic Account Executive who will be responsible for collaborating with cross-functional teams to win SaaS business, helping some of the largest pharmaceutical and CRO / CDMO organizations in the world, accelerate their critical milestones across the biopharma lifecycle from research to manufacturing.
This is a remote position based in Germany, which requires easy access and frequent travel to target accounts and customers in DACH and Nordics regions.
Vision : Forge executive relationships and deliver growth in IDBS’s key customers and targets. Deliver world class commercial planning and execution, aligned to company strategy while maintaining rigour in daily management and reporting
Engagement : Drive in-person engagement with key stakeholders within existing and target accounts. Build relationships and influence strategy for both short term and long term growth
Performance : Lead cross functional teams to win and expand customer accounts, acting as the visible owner of the account strategy and driving execution through SFDC
Results : Drive new logo acquisition and ARR expansion in portfolio of targeted top-tier accounts. Deliver accurate forecasting and on-time-delivery of new business bookings aligned to company business plans
Here is what success in this role looks like :
It would be a plus if you also possess previous experience in :
LI-EW2 #LI-REMOTE
Join our winning team today. Together, we’ll accelerate the real-life impact of tomorrow’s science and technology. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life.
For more information, visit
Jetzt bewerben
* The salary benchmark is based on the target salaries of market leaders in their relevant sectors. It is intended to serve as a guide to help Premium Members assess open positions and to help in salary negotiations. The salary benchmark is not provided directly by the company, which could be significantly higher or lower.